BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23780577)

  • 21. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
    Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation.
    Petramala L; Olmati F; Mancone M; Concistré A; Galassi M; Marinelli C; Tonnarini G; Lucia P; Costi U; Iannucci G; Sardella G; Letizia C
    Ann Med; 2017 Aug; 49(5):396-403. PubMed ID: 28084122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter-based renal sympathetic denervation for the treatment of resistant hypertension: first experience in Greece with significant ambulatory blood pressure reduction.
    Tsioufis C; Dimitriadis K; Tsiachris D; Thomopoulos C; Kasiakogias A; Kordalis A; Kefala A; Kallikazaros I; Stefanadis C
    Hellenic J Cardiol; 2012; 53(3):237-41. PubMed ID: 22653249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
    Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
    Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sympathetic denervation for refractory hypertension.
    Bunte MC
    Lancet; 2011 Mar; 377(9771):1074; author reply 1074-5. PubMed ID: 21440803
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk.
    Zaldivia MT; Rivera J; Hering D; Marusic P; Sata Y; Lim B; Eikelis N; Lee R; Lambert GW; Esler MD; Htun NM; Duval J; Hammond L; Eisenhardt SU; Flierl U; Schlaich MP; Peter K
    Hypertension; 2017 Feb; 69(2):323-331. PubMed ID: 27956575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure and sympathetic nervous system response to renal denervation.
    Schlaich M; Hering D; Lambert G; Lambert E; Esler M
    Hypertension; 2013 Feb; 61(2):e13. PubMed ID: 23248152
    [No Abstract]   [Full Text] [Related]  

  • 38. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal denervation: what next?
    Joyner MJ
    Hypertension; 2014 Jul; 64(1):19-20. PubMed ID: 24732888
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal denervation for resistant hypertension: not dead yet.
    Reddy VY; Olin JW
    J Am Coll Cardiol; 2014 Sep; 64(11):1088-91. PubMed ID: 25212641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.